Chargement en cours...
Effects of Natalizumab Treatment on Foxp3+ T Regulatory Cells
BACKGROUND: Natalizumab, a monoclonal humanized antibody targeting the alpha-4 chain of very late activation antigen 4 (VLA-4) exerts impressive therapeutic effects in patients with relapsing-remitting multiple sclerosis. Our objective was to study impacts of Natalizumab therapy on Foxp3+ T regulato...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Public Library of Science
2008
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2553177/ https://ncbi.nlm.nih.gov/pubmed/18836525 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0003319 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|